| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 10/01/2008 | EP1973569A2 Specific therapy using integrin ligands for treating cancer |
| 10/01/2008 | EP1973563A1 Method for the purification of alpha-1-antitrypsin |
| 10/01/2008 | EP1973562A2 Use of eif-5a to kill multiple myeloma cells |
| 10/01/2008 | EP1973561A2 Enzymes for reduced immunological stress |
| 10/01/2008 | EP1973560A2 Bovine osteopontin formulations for the improvement of the wound healing process |
| 10/01/2008 | EP1973559A2 Activin-actriia antagonists and uses for promoting bone growth |
| 10/01/2008 | EP1973558A2 Methods of treating obesity using enterostatin |
| 10/01/2008 | EP1973557A2 Non-hygroscopic compositions of enterostatin |
| 10/01/2008 | EP1973556A2 Histidine-containing diastereomeric peptides and uses thereof |
| 10/01/2008 | EP1973538A2 Method for treating huntington's disease by inhibiting dephosphorylation of huntingtin at s421 |
| 10/01/2008 | EP1709161B1 Human therapeutic cells secreting nerve growth factor |
| 10/01/2008 | EP1689355A4 Selective inhibitors of nuclear factor-kb activation and uses thereof |
| 10/01/2008 | EP1639080A4 A library of phylogenetically related sequences |
| 10/01/2008 | EP1611898B1 Composition for the prevention and treatment of cellulitis |
| 10/01/2008 | EP1496877B1 Method and composition for treatment of diabetes, hypertension, chronic heart failure and fluid retentive states |
| 10/01/2008 | EP1357936B1 Biocatalytic and biomimetic generation of nitric oxide in situ at substrate/blood interfaces |
| 10/01/2008 | EP1328258B1 A controlled-release, parenterally administrable microparticle preparation |
| 10/01/2008 | EP1317274B1 Peptide composition for treatment of periodontal diseases and prevention of skin aging |
| 10/01/2008 | EP1251862B1 Ophthalmic compositions for treating ocular hypertension |
| 10/01/2008 | EP1212295B1 Substituted alpha-hydroxy acid caspase inhibitors and the use thereof |
| 10/01/2008 | EP1142590B1 Gene therapy for diabetic ischemic disease |
| 10/01/2008 | EP1135113B1 Treatment of parkinson's disease with oligonucleotides |
| 10/01/2008 | EP1129111B1 Methods for conversion of interferon isoforms and products thereof |
| 10/01/2008 | EP1102847B1 Novel tension-dependent potassium channel and the use thereof in the development of new therapeutic agents |
| 10/01/2008 | EP0804486B1 Granulocyte chemotactic protein |
| 10/01/2008 | EP0766512B1 Replication-competent herpes simplex virus mediates destruction of neoplastic cells |
| 10/01/2008 | EP0739207B1 Enteral formula with ribo-nucleotides |
| 10/01/2008 | CN101277722A Composition and method for prevention and treatment of type I diabetes |
| 10/01/2008 | CN101277715A Treatment of neurodegenerative disorders |
| 10/01/2008 | CN101277714A Methods for treating immune mediated neurological diseases |
| 10/01/2008 | CN101277713A Composition for acceleration of type I collagen production |
| 10/01/2008 | CN101277612A Composition and method for use in cartilage affecting conditions |
| 10/01/2008 | CN101275136A Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin d metabolism and DNAs encoding the same |
| 10/01/2008 | CN101275126A Purified high-specific-activity recombinant batroxobin |
| 10/01/2008 | CN101275124A Recombinant bacterial phytases and uses thereof |
| 10/01/2008 | CN101274961A Recombinant human parathyroid hormone related protein |
| 10/01/2008 | CN101274959A Proteinase k resistant surface protein of neisseria meningitidis |
| 10/01/2008 | CN101274099A Method for preparing polymer matrix with transfer function |
| 10/01/2008 | CN101274096A Stable Batroxobin medicament composition |
| 10/01/2008 | CN101274095A Humic acid detoxification peptide compound preparation and method for preparing the same |
| 10/01/2008 | CN101274094A Gubao tablets and technique for producing and preparing the same |
| 10/01/2008 | CN101273995A Method for preparing magnetic particles modified by afi-tiazin dyes and application |
| 10/01/2008 | CN101273988A Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles |
| 10/01/2008 | CN101273961A Glucose-sensitive hydrogels |
| 10/01/2008 | CN101273913A Intramedullary nail device and medication thereof |
| 10/01/2008 | CN100422716C Gas sensor |
| 10/01/2008 | CN100422343C Method of distinguishing drug-resistance of hepatitis b virus |
| 10/01/2008 | CN100422332C Expression and export of angiostation and endostatin as immunofusins |
| 10/01/2008 | CN100422322C Foot and mouth disease virus vaccine |
| 10/01/2008 | CN100422320C DNA sequences encoding dystrophin minigenes and methods of use thereof |
| 10/01/2008 | CN100422212C Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
| 10/01/2008 | CN100422211C Antagonistic analogs in GH-RH inhibiting IGF-I and -II |
| 10/01/2008 | CN100422208C Hemiasterlin analogs |
| 10/01/2008 | CN100421731C Injection liquid of human autogenous collagen living cell and preparation method thereof |
| 10/01/2008 | CN100421729C Effervescence tablet of human antalzyme, its preparation and usage |
| 10/01/2008 | CN100421728C Cordyceps sinensis and emu collagens peptide capsules and production thereof |
| 10/01/2008 | CN100421727C Methods |
| 10/01/2008 | CN100421726C Nano compound eye-drop containing piptide-like medicine and preparing method |
| 10/01/2008 | CN100421696C Medicament for treating mastopathy |
| 10/01/2008 | CN100421667C Method for treating and preventing hyperparathyroidism |
| 10/01/2008 | CA2654894A1 Csf3r polypeptides and uses thereof |
| 09/30/2008 | USRE40525 Hepatitis C inhibitor tri-peptides |
| 09/30/2008 | US7430476 Method for identification of t-cell epitopes and use for preparing molecules with reduced immunogenicity |
| 09/30/2008 | US7429693 Method for the production of plant seed with modified fiber content and modified seed coat |
| 09/30/2008 | US7429648 IREN protein, its preparation and use |
| 09/30/2008 | US7429647 Polypeptides capable of forming antigen binding structures with specificity for the Rhesus D antigens, the DNA encoding them and the process for their preparation and use |
| 09/30/2008 | US7429643 POSH nucleic acids, polypeptides and related methods |
| 09/30/2008 | US7429640 PRO6181 polypeptides |
| 09/30/2008 | US7429639 SSX-2 peptides presented by HLA class II molecules |
| 09/30/2008 | US7429618 substituted triarylmethane compounds for immunosuppressive treatment of autoimmune disorders or inflammatory diseases; [Tris-(4-fluoro-phenyl)-methyl]-phosphonic acid dimethyl ester; Gardos channel antagonists |
| 09/30/2008 | US7429614 Medicament containing an effector of the glutathione metabolism together with α-lipoic acid for treating diabetes mellitus |
| 09/30/2008 | US7429567 Sustained delivery of PDGF using self-assembling peptide nanofibers |
| 09/30/2008 | US7429566 Method for treating Hemophilia B |
| 09/30/2008 | US7429565 Antiviral phosphonate analogs |
| 09/30/2008 | US7429564 Orally administering insulin and delivery agent 4-[(4-chloro, 2-hydroxybenzoyl)amino]butanoic acid that facilitates the absorption of insulin from the gastrointestinal tract; diabetes mellitus; bioavailability comparable to injection; treating diabetes without the drawbacks of systemic hyperglycemia |
| 09/30/2008 | US7429563 Sequences of myeloperoxidase (MPO) that serve as albumin docking proteins (ADPs); e.g. sequence ELKSLNPRWDGE; conjugates with other drugs or biodrugs such as insulin to improve uptake via transcytosis |
| 09/30/2008 | US7429562 Form a clear microemulsion upon contact with an aqueous medium; preconcentrates; reduced toxicity but high bioavailability; contain cyclosporin A analog ISATx247 (Voclosporin), tocopheryl polyethylene glycol 1000 succinate (Vitamin E TPGS), medium chain triglyceride (MCT) oil, emulsifier, and ethanol |
| 09/30/2008 | US7429561 Method for stimulating cell growth using sponge protein hydrolysates |
| 09/30/2008 | US7429560 Ketoamide inhibitors in chronic nerve disease |
| 09/30/2008 | US7429559 Controlled release composition and method of producing the same |
| 09/30/2008 | US7429489 Population of hematopoietic cells, made to exhibit a greater clonogenic potential, engraftment potential, immune system reconstitution potential and/or proportion of CD34+ positive cells by culturing with a transition metal compound that chelates copper such as tetraethylenepentamine |
| 09/30/2008 | US7429488 Method for processing lipoaspirate cells |
| 09/30/2008 | US7429483 Use of nerve growth factor for the storage, culture or treatment of cornea |
| 09/30/2008 | US7429474 2-O sulfatase compositions and methods of analyzing therewith |
| 09/30/2008 | US7429461 Genetic products differentially expressed in tumors and use thereof |
| 09/30/2008 | US7429448 Therapeutic use of the SMR1 protein and active derivatives thereof |
| 09/30/2008 | US7429389 inactivated or attenuated Mycoplasma bovis biotype and a carrier; vaccinating cows; no undesirable side effects and protect against M. bovis related disease, such as contagious mastitis, respiratory pneumonia, joint infections, keratoconjunctivitis and middle ear infections |
| 09/30/2008 | US7429388 Vaccine for nontypeable Haemophilus influenzae infection |
| 09/30/2008 | US7429387 Administering neurotoxin |
| 09/30/2008 | US7429386 Administering botulinum toxin to a non-surgically formed stretch mark or to the vicinity of the non-surgically formed stretch mark |
| 09/30/2008 | US7429384 Autoimmune diseases, graft rejections, chronic inflammations, sepsis, ischemia and reperfusion syndrome and atherosclerosis |
| 09/30/2008 | US7429383 Improves the efficiency of targeting cells to the bone marrow, and/or to modulate hematopoietic progenitor cell function |
| 09/30/2008 | US7429379 TNF receptor action modulation |
| 09/30/2008 | US7429378 treating degenerative disc disease in an intervertebral disc having a nucleus pulposus by administering a high affinity anti-matrix metalloproteinase (HAAMMP) into an intravertebral disc; does not inhibit non-targeted cells, tissue or proteins; offers aging resistance |
| 09/30/2008 | US7429377 Therapeutic composition containing a plurality of immobilized proteases |
| 09/30/2008 | US7429375 Proteoglycan degrading mutants for the treatment of CNS |
| 09/30/2008 | US7429374 Determining if a batch of glatiramer acetate is acceptable for pharmaceutical use |
| 09/30/2008 | CA2505933C Use of botulinum toxin for treating urinary incontinence |
| 09/30/2008 | CA2453646C 5-cnac as oral delivery agent for parathyroid hormone fragments |
| 09/30/2008 | CA2405716C Chemically modified novel erythropoietin stimulating protein compositions and methods |